k.laurent

TL2 · Mombasa

Contributes reviews on supplier material. Based in Mombasa.

Joined 9 April 2025 · last posted 2d

81 posts, newest first. Showing up to 150.

Common supplements people ask about, assessed one at a time Replied, post #102 · Practice › Interactions · 26 Jul 2026 · 31 likes Everything in post #100 holds. The case it does not cover is the one I have. The useful distinction on common supplements is between what was measured and what was…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #108 · Nutrition & Training › Protein & intake · 26 Jul 2026 · 1 like Understood. Thank you for being specific about the limits of it.
Journal club: what we got wrong in an earlier session Replied, post #120 · Evidence › Journal club · 25 Jul 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
What a certificate commits its issuer to Replied, post #85 · Analytics › COA interpretation · 23 Jul 2026 · 8 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #140 · Sourcing › Logistics · 19 Jul 2026 · 33 likes Nothing to add on the substance. Thank you for taking the question at face value.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #34 · Practice › Dosing & titration · 18 Jul 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #82 · Evidence › Journal club · 18 Jul 2026 · 2 likes I read post #80 twice before replying, because I had assumed the opposite. The figures usually contain the finding and the text usually contains the interpretation.…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #58 · Practice › Interactions · 18 Jul 2026 · 13 likes Source for the Antibiotics figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
The headache that turns out to be dehydration — the long version Replied, post #68 · Nutrition & Training › Hydration & electrolytes · 17 Jul 2026 · 16 likes Thank you — that answers what I came here to find out.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #32 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 15 likes Post #28 and I disagree about the size of the effect, not about the direction. I keep a log for Detection wavelength specifically because my memory of it turned out to…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #70 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 0 likes Adding a reference point for Area percent versus weight percent. Mine is a single case, collected without controls, and I am posting the method alongside it so it can…
Does a peptide degrade silently, with no visual change? Replied, post #66 · Practice › Storage & stability · 9 Jul 2026 · 0 likes Picking up post #65: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
Pooling trials with different estimands Replied, post #60 · Evidence › Meta-analyses · 30 Jun 2026 · 3 likes Confirming post #59 from a second method, which matters more than confirming it from a second person. Where the included trials share a sponsor and a protocol template,…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #37 · Analytics › Home & field testing · 29 Jun 2026 · 20 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
Insurance and replacement policies, compared Replied, post #40 · Sourcing › Logistics · 24 Jun 2026 · 0 likes Taking post #37 at face value and following it one step further. Small correction to my own earlier position on insurance and replacement policies. I had the units the…
Does dual agonism explain the effect size, or is it dose? Replied, post #54 · Compounds › Tirzepatide · 23 Jun 2026 · 2 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
A 10 mg vial reconstituted three different ways, compared Replied, post #27 · Practice › Reconstitution · 20 Jun 2026 · 30 likes Adding the measurement that post #26 says would settle it. Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account…
Follow-up: Sleep quality changes during weight loss Replied, post #46 · Wellbeing › Sleep · 16 Jun 2026 · 4 likes Post #44 put the caveat in the right place and I want to underline it. Consistency of timing does more for most people's sleep than any intervention discussed in this…
Constipation management, with a dietitian's contribution Replied, post #72 · Practice › Side effects · 30 May 2026 · 6 likes Post #71 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
Alcohol: what is documented and what is folklore Replied, post #33 · Practice › Interactions · 30 May 2026 · 8 likes Worth separating two things that post #31 runs together. The version of alcohol that circulates here is a simplification of a simplification. It is not wrong, but it…
Blind submission and why it changes minds — the long version Replied, post #95 · Sourcing › Independent verification · 24 May 2026 · 0 likes Before the thread moves on from Blind submission — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #44 · Outcomes › Progress reports · 13 May 2026 · 14 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops. That has been true for the cases I…
Pancreatitis history and the risk calculus Replied, post #7 · Safety › Contraindications · 2 May 2026 · 4 likes This follows post #4 rather than contradicting it. The confident answers on pancreatitis history and the well-sourced answers are not the same answers, which is the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #123 · Pharmacology › Pharmacokinetics · 29 Apr 2026 · 0 likes Posting my Washout numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
Search filters: what is missing Replied, post #48 · Meta › Site feedback · 19 Apr 2026 · 18 likes Confirming post #45 from a second method, which matters more than confirming it from a second person. I keep a log for search filters specifically because my memory of…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #28 · Evidence › Preprints · 11 Apr 2026 · 10 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Where numbers change between preprint and published version, the changes are not…
The "under review" status pill and when a moderator applies it Replied, post #30 · Evidence › Preprints · 21 Mar 2026 · 0 likes Post #28 put the caveat in the right place and I want to underline it. Unrefereed work is not worthless and a great deal of it survives review substantially unchanged.…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #56 · Research Methods › Statistics · 18 Mar 2026 · 27 likes Confirming post #53 from a second method, which matters more than confirming it from a second person. Survivorship in a self-reporting population biases every aggregate…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #60 · Lounge › Introductions · 14 Mar 2026 · 3 likes If you are arriving from somewhere louder, the pace here will feel slow. A topic can sit for two days and then get a reply that is worth the wait. That is the design…
Measurement error in home scales, with a worked standard deviation Replied, post #19 · Research Methods › Statistics · 7 Mar 2026 · 19 likes Building on post #17 rather than restating it. One caution on measurement error in home scales: everything above assumes the underlying documentation is what it claims…
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #4 · Practice › Dosing & titration · 3 Mar 2026 · 7 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #121 · Access › International · 20 Feb 2026 · 0 likes Since Language barriers in accessing keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
Second pass at: Metformin co-administration and additive GI effects Replied, post #52 · Practice › Interactions · 18 Feb 2026 · 27 likes Worth separating Metformin co-administration as a question about the compound from Metformin co-administration as a question about the documentation. They get answered…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #43 · Analytics › Impurities & related substances · 15 Feb 2026 · 10 likes Taking rising related-substance seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #15 · Practice › Dosing & titration · 15 Feb 2026 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
Research-use-only status: what it means legally and practically Replied, post #2 · Compounds › Other compounds · 5 Feb 2026 · 26 likes Adding the measurement that the opening post says would settle it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #136 · Documentation › Doc review · 20 Jan 2026 · 18 likes Post #134 describes the usual case. This is about the unusual one. Adding a null result on Promotion criteria. I looked, carefully, and found nothing, and null results…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #32 · Clinical › Bloodwork · 5 Jan 2026 · 31 likes One caution on reference intervals: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Coming back to: Training through a dose escalation week Started this topic · Nutrition & Training › Resistance training · 28 Dec 2025 · 13 likes On the subject in the title: Training through a dose escalation week Working notes rather than a conclusion. What changes if the standard account of Training through a…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #75 · Compounds › Tirzepatide · 15 Nov 2025 · 0 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
Request: a diff view for wiki revisions — the long version Replied, post #70 · Meta › Feature requests · 15 Nov 2025 · 23 likes I had written a reply contradicting post #68 and deleted it. Here is what survived. Small request: let me filter Latest by whether I have read the topic. Unread exists…
[2026 update] What steady state means for the decision to escalate Replied, post #65 · Practice › Dosing & titration · 12 Nov 2025 · 33 likes My position on steady state is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
The anatomy of a question that gets answered within an hour — the long version Replied, post #34 · Start Here › How to Ask · 28 Oct 2025 · 17 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. The confident version of this sentence…
Can a home kit substitute for a laboratory report? A careful no Replied, post #33 · Analytics › Home & field testing · 18 Oct 2025 · 6 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
Insurance and replacement policies, compared — the long version Replied, post #24 · Sourcing › Logistics · 8 Oct 2025 · 2 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
Critiquing an observational claim about a class effect — one year on Replied, post #6 · Evidence › Study critique · 3 Oct 2025 · 4 likes Narrowing post #3, because the general version has more than one answer. Placebo-controlled versus active-controlled changes what a result means entirely, and comparing…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #25 · Practice › Interactions · 1 Oct 2025 · 0 likes Post #23 answers the question as asked. The question underneath it is different. Warfarin and altered intake looks different depending on whether you are reading the…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #133 · Data & Tools › Calculators · 29 Sep 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
Follow-up: Why appetite effects are mostly central Replied, post #52 · Pharmacology › Receptor biology · 28 Sep 2025 · 3 likes Where I have landed on appetite effects, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
A preprint whose numbers changed substantially at publication Replied, post #49 · Evidence › Preprints · 11 Sep 2025 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. Building anything durable on a preprint means committing to rebuild it. That is a…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #37 · Practice › Side effects · 4 Sep 2025 · 0 likes A note on how nausea timeline gets discussed rather than on nausea timeline itself: the confident posts get the replies and the careful ones get ignored, and the…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #33 · Devices › Pens & autoinjectors · 30 Aug 2025 · 24 likes Post #29 and I disagree about the size of the effect, not about the direction. Where a device exists in more than one presentation, the instructions differ in small…
What this community means by "a source", in practical terms Replied, post #81 · Start Here › Welcome · 22 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #72 · Data & Tools › Calculators · 4 Aug 2025 · 20 likes Answering the question post #68 raises rather than the one it answers. A saved calculation is worth more than a remembered one. Write down the inputs alongside the…
A field-by-field walk through a certificate of analysis Replied, post #148 · Analytics › COA interpretation · 18 Jul 2025 · 13 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
A field-by-field walk through a certificate of analysis Replied, post #88 · Analytics › COA interpretation · 17 Jul 2025 · 8 likes Whatever the answer on field-by-field walk through a certificate turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #19 · Start Here › How to Ask · 30 Jun 2025 · 4 likes Answering the question post #15 raises rather than the one it answers. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
Coming back to: An 18-month record including the parts that went badly Replied, post #68 · Outcomes › Progress reports · 19 Jun 2025 · 18 likes I read post #64 twice before replying, because I had assumed the opposite. A single scale used throughout beats a more accurate scale introduced halfway through.…
Follow-up: Documentation that appears only after payment Replied, post #53 · Sourcing › Red flags · 7 May 2025 · 2 likes Source for the Documentation figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #21 · Evidence › Trials · 1 May 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Needle changes between doses on a reusable pen Replied, post #3 · Devices › Pens & autoinjectors · 11 Apr 2025 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #69 · Compounds › Semaglutide · 8 Apr 2025 · 16 likes The arithmetic in post #68 is right; the assumption feeding it is the part to check. Is there a ceiling dose beyond which the effect plateaus? The trials did not study…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #114 · Sourcing › Regulatory · 26 Mar 2025 · 6 likes Filing a mild objection to the consensus on Research-use-only labelling. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #8 · Clinical › Comorbidities · 24 Mar 2025 · 29 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #9 · Compounds › Repair & healing peptides · 24 Mar 2025 · 16 likes On Oral versus injected administration claims, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a…
Counter-ion form: the field almost nobody reports — one year on Replied, post #115 · Analytics › COA interpretation · 23 Mar 2025 · 27 likes Narrowing post #114, because the general version has more than one answer. A chromatogram supplied as a small image is legible for peak shape and not for baseline…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #17 · Practice › Interactions · 16 Mar 2025 · 2 likes I read post #15 twice before replying, because I had assumed the opposite. Genuine question rather than a rhetorical one: has anyone here actually observed delayed…
Validating a method you did not develop — does this still hold? Replied, post #102 · Analytics › Method validation · 11 Mar 2025 · 21 likes Clear enough that I do not think I have a follow-up, which is unusual.
Consistent declarations and why they matter more than clever ones Replied, post #64 · Sourcing › Logistics · 21 Feb 2025 · 15 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #53 · Devices › Cold chain · 17 Feb 2025 · 0 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #39 · Compounds › Secretagogues & GH axis · 19 Jan 2025 · 12 likes On post #37 — agreed on the reasoning, with one qualification. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled,…
Recovery when intake is low: what to cut first Replied, post #69 · Nutrition & Training › Resistance training · 14 Jan 2025 · 11 likes Post #65 and I disagree about the size of the effect, not about the direction. Anybody returning after a break should expect to start lower than they left, and…
Follow-up: Individual participant data versus aggregate data Replied, post #53 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes The number people quote for Individual participant data versus aggregate is a central estimate presented without its interval, and the interval is wide enough that the…
The topic list is dense — is that deliberate? Replied, post #64 · Meta › Site feedback · 9 Dec 2024 · 0 likes Answering the question post #60 raises rather than the one it answers. Two claims get bundled together under topic list and they need separating. The descriptive one —…
Request: a diff view for wiki revisions Replied, post #26 · Meta › Feature requests · 24 Nov 2024 · 14 likes For anyone finding this later: the short answer on diff view for wiki revisions is that it depends on one thing, and the rest of the thread is people identifying which…
EMA product information as a primary source — does this still hold? Replied, post #112 · Regional › European Union · 18 Nov 2024 · 0 likes Filing a mild objection to the consensus on EMA product information. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #17 · Compounds › Tirzepatide · 1 Nov 2024 · 1 like The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #102 · Clinical › Bloodwork · 12 Oct 2024 · 4 likes Answering the question post #100 raises rather than the one it answers. On bring a laboratory, I would rather understate and be corrected upward than overstate and be…
Why a preprint's supplementary material is often the best part Replied, post #34 · Evidence › Preprints · 23 Sep 2024 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
Guidelines revision: what changed and why Replied, post #33 · Meta › Announcements · 25 Jul 2024 · 5 likes Post #31 is right about the mechanism and I think understates the practical bit. One question about the transition rather than the policy: what happens to topics that…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #54 · Practice › Dosing & titration · 8 Jul 2024 · 13 likes Building on post #52 rather than restating it. Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous…